Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 25.87 Min. order: 1 piece ★★★★★ 4.7 (270 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 25.22 Min. order: 1 piece ★★★★★ 4.1 (209 reviews) Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 20.88 Min. order: 1 piece ★★★★★ 4.5 (218 reviews) Sold : Login>>
GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction US$ 27.50 Min. order: 1 piece ★★★★★ 5.0 (289 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 25.72 Min. order: 1 piece ★★★★★ 5.0 (17 reviews) Sold : Login>>